News
After Two Cancer Diagnoses, Young Cancer Survivor Looks Ahead with Confidence
... Here goes the content ...
Miller School research helped advance laromestrocel, an investigational stem cell therapy for aging frailty, to the XPRIZE Healthspan final. Miller School researchers found that higher p-tau181 blood levels were linked to poorer memory performance six years later in older adults. A TMEM106B variant is linked to TDP-43 pathology in Alzheimer’s disease, offering clues to why cognitive decline differs among patients. Sylvester researchers are studying whether routine nutrition and immune markers can help predict symptom burden during and after chemotherapy.
Miller School of Medicine Stem Cell Research Advances to XPRIZE Healthspan Final

Blood Biomarker May Signal Memory Vulnerability Years Before Cognitive Changes

TMEM106B Variant Linked to TDP-43 Pathology in Alzheimer’s Disease

Can Routine Lab Data Predict Chemotherapy Side Effects?






